C
Sanofi SNY
$49.75 -$0.72-1.43% NASDAQ
Recommendation
Prev Close
$50.47
Volume
1,734,628
Avg Vol (90D)
2,740,266
Market Cap
$122.65B
Dividend & Yield
$1.61(3.19%)
52-Week Range
$45.80 - $60.12
P/E (TTM)
20.06
EPS (TTM)
$2.52
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Analysts Think These Stocks Could More Than Double in Value
5/23/2025 - MarketBeat
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
6/9/2025 - CNBC: World News
Sanofi (SNY) Accelerates Beyfortus Distribution for RSV Season
6/9/2025 - GuruFocus
Sanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care
6/9/2025 - CNW Group - News Releases
Acquisitions, Licensing Deals Take Centerstage in Pharma/Biotech Space
6/9/2025 - Zacks Investment Research
Patriot Financial Group Insurance Agency LLC Raises Holdings in Sanofi (NASDAQ:SNY)
6/9/2025 - Ticker Report
Foundation Resource Management Inc. Sells 11,605 Shares of Sanofi (NASDAQ:SNY)
6/9/2025 - MarketBeat
feeling rsv heat merck sanofi lays out supply plans beyfortus
6/9/2025 - FiercePharma
Priebe Wealth Holdings LLC Takes $221,000 Position in Sanofi (NASDAQ:SNY)
6/9/2025 - Ticker Report
gsk snags long time sanofi exec lead vaccine and infectious disease rd
6/9/2025 - FierceBiotech.com - Biotech
Sanofi (SNY) Expands Beyfortus Production Ahead of RSV Season
6/9/2025 - GuruFocus
Sanofi speeds up Beyfortus shipping ahead of 2025-2026 RSV season
6/9/2025 - SeekingAlpha.com: All News
Sanofi speeds up Beyfortus shipping ahead of 2025-2026 RSV season
6/9/2025 - Seeking Alpha - Healthcare
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
6/9/2025 - Globe Newswire
Regeneron, Sanofi presents results from DISCOVER Phase 4 trial of Dupixent
6/8/2025 - TipRanks Financial Blog
Regeneron, Sanofi presents results from DISCOVER Phase 4 trial of Dupixent
6/8/2025 - The Fly
Notable healthcare headlines for the week: Bristol Myers Squibb, Novo Nordisk and Sanofi in focus
6/8/2025 - SeekingAlpha.com: All News
Top global stories this week: UBS, Toyota Motor, Sanofi among major names
6/8/2025 - SeekingAlpha.com: All News
Top global stories this week: UBS, Toyota Motor, Sanofi among major names
6/8/2025 - Seeking Alpha - Japan Stocks
Lloyd Advisory Services LLC. Invests $227,000 in Sanofi (NASDAQ:SNY)
6/8/2025 - Ticker Report
Regeneron Pharmaceuticals Inc (REGN) Announces Promising Results from Dupixent Trial in Atopic ...
6/8/2025 - GuruFocus
Regeneron Pharmaceuticals Inc (REGN) Announces Promising Results from Dupixent Trial in ...
6/7/2025 - GuruFocus
Dupixent (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color
6/7/2025 - Globe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY
6/7/2025 - GuruFocus
Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
2/27/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$137.49B
Total Debt (Q)
$18.55B
Total Liabilities (Q)
$56.88B
Book Value Per Share (Q)
$64.01
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, February 13, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
(est)
Price History
Loading...
Beta
0.29
7-Day Total Return
-4.97%
30-Day Total Return
-1.88%
60-Day Total Return
-11.11%
90-Day Total Return
-1.56%
Year to Date Total Return
6.53%
1-Year Total Return
4.81%
2-Year Total Return
3.97%
3-Year Total Return
1.17%
5-Year Total Return
12.78%
52-week Low
Dec 16, 2024 - $45.80
52-week High
Mar 10, 2025 - $60.12
Valuation
Market Cap
$122.65B - Large Cap
Enterprise Value
$134.85B
Price/Sales (TTM)
1.81
Price/Book (Q)
0.79
Dividends and Shares
Shares Outstanding
1.25B
Dividend Per Share (Most Recent)
$1.61
Dividend Per Share (TTM)
$1.61
Corporate Info
Website
www.sanofi.com
Phone Number
33 1 53 77 40 00
Address
46, avenue de la Grande Armée
Paris, 75017
Country
France
Year Founded
1994
Business Description
Sector
--
Industry
--
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides... more
NASDAQ 06/09/2025 4:00PM Eastern Quotes delayed